Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin D and the parathyroid.

P Beckerman1, J Silver

  • 1Minerva Center for Calcium and Bone Metabolism, Nephrology Services, Hadassah University Hospital, Jerusalem, Israel.

The American Journal of the Medical Sciences
|June 18, 1999
PubMed
Summary

Vitamin D

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient preferences for treatment of chronic rhinosinusitis with nasal polyps.

Rhinology·2025
Same author

Indicators are Relational: Navigating Knowledge and Power in the Development and Implementation of Coastal-Marine Indicators.

Environmental management·2022
Same author

Operative efficiency: comparison of methods to optimize the use of chlorhexidine gluconate applicators.

The Journal of hospital infection·2021
Same author

Ultrathin Y<sub>2</sub>O<sub>3</sub>:Eu<sup>3+</sup>nanodiscs: spectroscopic investigations and evidence for reduced concentration quenching.

Nanotechnology·2018
Same author

St Hugh's Military Hospital (Head Injuries), Oxford 1940-1945.

The journal of the Royal College of Physicians of Edinburgh·2017
Same author

The place of James Arnott (1797-1883) in the development of local anaesthesia in dentistry.

British dental journal·2016

Area of Science:

  • Endocrinology and Mineral Metabolism

Background:

  • The active form of Vitamin D, 1,25(OH)2D3, significantly influences parathyroid cells.
  • This metabolite plays a crucial role in mineral metabolism and secondary hyperparathyroidism management in chronic kidney disease.

Purpose of the Study:

  • To explore the multifaceted effects of 1,25(OH)2D3 on parathyroid hormone (PTH) regulation.
  • To investigate the therapeutic potential of novel non-hypercalcemic Vitamin D analogs.
  • To understand the interplay between Vitamin D and PTH gene regulation in hypocalcemic and hypophosphatemic states.

Main Methods:

  • Analysis of 1,25(OH)2D3's impact on PTH gene transcription, synthesis, and secretion.
  • Evaluation of 1,25(OH)2D3's effect on parathyroid cell proliferation.
  • Examination of Vitamin D receptor (VDR) expression and genotype associations in secondary hyperparathyroidism.

Main Results:

  • 1,25(OH)2D3 significantly reduces parathyroid hormone (PTH) gene transcription, synthesis, and secretion.
  • 1,25(OH)2D3 inhibits parathyroid cell proliferation.
  • Down-regulation of the Vitamin D receptor (VDR) is observed in nodular secondary hyperparathyroidism.
  • Specific VDR genotypes correlate with elevated PTH levels and hyperplasia predisposition.

Conclusions:

  • 1,25(OH)2D3 is a key regulator of parathyroid function, impacting PTH levels and cell growth.
  • Development of non-hypercalcemic Vitamin D analogs offers potential therapeutic advantages.
  • VDR status and genotype are critical factors in secondary hyperparathyroidism, influencing disease progression and treatment response.

Related Experiment Videos